文献速递认知障碍与痴呆

巴尔的摩老龄化纵向研究中疱疹病毒与脑体积、认知表现及血浆生物标志物的关联

Herpes Viruses in the Baltimore Longitudinal Study of Aging: Associations With Brain Volumes, Cognitive Performance, and Plasma Biomarkers.
PubMed 文献 · Neurology · 2022-10-31

该纵向社区队列研究纳入1009名参与者,分析有症状疱疹病毒(sHHV)感染与脑体积变化、认知表现及血浆AD/神经退行性生物标志物的关联。sHHV诊断与白质体积纵向减少、注意力加速下降及血浆GFAP升高相关,但与Aβ42/40和NfL无关。

要点

  • sHHV诊断与白质体积纵向额外年变化率-0.34 cm3/y相关(p=0.035),以颞叶为主。
  • sHHV诊断与注意力纵向额外年变化率-0.01 Z-score/年相关(p=0.008)。
  • sHHV诊断与血浆GFAP升高相关,与Aβ42/40和NfL无关联。

核心结论

  • sHHV感染与白质体积丢失、注意力下降及星形胶质细胞增生相关,但不支持sHHV与AD特异性疾病过程相关。

研究设计与样本

  • 巴尔的摩老龄化纵向研究,社区招募的纵向队列,纳入1009名参与者进行主要MRI分析,基线MRI时98%认知正常(平均年龄65.7岁;54.8%女性)。

主要发现

  • sHHV诊断(N=119)与白质体积纵向减少相关(额外年变化率-0.34 cm3/y;p=0.035),尤以颞叶为著。
  • sHHV与总脑、总灰质或AD特征区域体积变化无关联。
  • 在119名sHHV参与者中,抗病毒治疗暴露减弱枕叶白质下降(p=0.04)。
  • sHHV组基线认知评分较高,但sHHV诊断与注意力纵向加速下降相关(额外年变化率-0.01 Z-score/年;p=0.008)。
  • sHHV诊断与血浆GFAP升高相关,与Aβ42/40和NfL水平无关。

关键数值与推荐

  • sHHV分类采用每次研究访视时综合健康与功能筛查评估中记录的ICD-9编码。
  • MRI和认知评估的平均随访时间分别为3.4年(SD=3.2)和8.6年(SD=7.7)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Although an infectious etiology of Alzheimer disease (AD) has received renewed attention with a particular focus on herpes viruses, the longitudinal effects of symptomatic herpes virus (sHHV) infection on brain structure and cognition remain poorly understood, as does the effect of sHHV on AD/neurodegeneration biomarkers. METHODS: We used a longitudinal, community-based cohort to characterize the association of sHHV diagnoses with changes in 3 T MRI brain volume and cognitive performance. In addition, we related sHHV to cross-sectional differences in plasma biomarkers of AD (β-amyloid [Aβ]42/40), astrogliosis (glial fibrillary acidic protein [GFAP]), and neurodegeneration (neurofilament light [NfL]). Baltimore Longitudinal Study of Aging participants were recruited from the community and assessed with serial brain MRIs and cognitive examinations over an average of 3.4 (SD = 3.2) and 8.6 (SD = 7.7) years, respectively. sHHV classification used International Classification of Diseases, Ninth Revision codes documented at comprehensive health and functional screening evaluations at each study visit. Linear mixed-effects and multivariable linear regression models were used in analyses. RESULTS: A total of 1,009 participants were included in the primary MRI analysis, 98% of whom were cognitively normal at baseline MRI (mean age = 65.7 years; 54.8% female). Having a sHHV diagnosis (N = 119) was associated with longitudinal reductions in white matter volume (annual additional rate of change -0.34 cm3/y; p = 0.035), particularly in the temporal lobe. However, there was no association between sHHV and changes in total brain, total gray matter, or AD signature region volumes. Among the 119 participants with sHHV, exposure to antiviral treatment attenuated declines in occipital white matter (p = 0.04). Although the sHHV group had higher cognitive scores at baseline, sHHV diagnosis was associated with accelerated longitudinal declines in attention (annual additional rate of change -0.01 Z-score/year; p = 0.008). In addition, sHHV diagnosis was associated with elevated plasma GFAP, but not related to Aβ42/40 and NfL levels. DISCUSSION: These findings suggest an association of sHHV infection with white matter volume loss, attentional decline, and astrogliosis. Although the findings link sHHV to several neurocognitive features, the results do not support an association between sHHV and AD-specific disease processes.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Duggan MR, Peng Z, An Y, et al. Herpes Viruses in the Baltimore Longitudinal Study of Aging: Associations With Brain Volumes, Cognitive Performance, and Plasma Biomarkers. Neurology. 2022. PMID: 35985823. doi:10.1212/WNL.0000000000201036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。